Loading clinical trials...
Loading clinical trials...
Mitral regurgitation (MR) is one of the most common valvular heart diseases in China, causing heart failure. Patients with moderate to severe MR have a very poor clinical prognosis if no intervention ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sun Yat-sen University
NCT04430075 · Mitral Regurgitation, Mitral Insufficiency
NCT06465745 · Mitral Regurgitation, Mitral Insufficiency, and more
NCT06911099 · Atrial Functional Mitral Regurgitation, Mitral Insufficiency
NCT06377449 · Ischemic Heart Disease, Aortic Stenosis, Severe, and more
NCT03433274 · Mitral Regurgitation, Mitral Insufficiency, and more
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions